4-(2-Amino-1-hydroxy-ethyl)-phenol

ID: ALA53929

Chembl Id: CHEMBL53929

Cas Number: 104-14-3

PubChem CID: 4581

Max Phase: Phase

Molecular Formula: C8H11NO2

Molecular Weight: 153.18

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: ND 50 | ND-50 | NSC-757399 | octopamine|Norsynephrine|104-14-3|4-(2-Amino-1-hydroxyethyl)phenol|Norsympatol|Norsympathol|Norden|Norphen|Analet|octopaminum|Octapamine|Octopamina|p-Norsynephrin|Octopamine [INN]|Paraoxyphenyl aminoethanol|ND 50|1-(p-Hydroxyphenyl)-2-aminoethanol|Octopaminum [Latin]|Octopamin|WIN 5512|Octopaminum [INN-Latin]|p-Hydroxyphenylethanolamine|beta-hydroxytyramine|Octopamina [INN-Spanish]|alpha-(Aminoethyl)-4-hydroxybenzenemethanol|alpha-(Aminomethyl)-p-hydroxybenzyl alcohoShow More

Canonical SMILES:  NCC(O)c1ccc(O)cc1

Standard InChI:  InChI=1S/C8H11NO2/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4,8,10-11H,5,9H2

Standard InChI Key:  QHGUCRYDKWKLMG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA53929

    OCTOPAMINE
  2. Alternative Forms:

Associated Targets(Human)

HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFE2L2 Tchem Nuclear factor erythroid 2-related factor 2 (95332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MPHOSPH8 Tbio M-phase phosphoprotein 8 (656 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EHMT2 Tchem Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (93046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RGS4 Tchem Regulator of G-protein signaling 4 (13867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLS Tchem Glutaminase kidney isoform, mitochondrial (16997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ARSA Tbio Cerebroside-sulfatase (655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
POU2F1 Tbio POU domain, class 2, transcription factor 1 (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra1b Adrenergic receptor alpha (950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pfk 6-phospho-1-fructokinase (7870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pmp22 Peripheral myelin protein 22 (1279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
oa1 Octopamine receptor (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Taar1 Trace amine-associated receptor 1 (899 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 153.18Molecular Weight (Monoisotopic): 153.0790AlogP: 0.38#Rotatable Bonds: 2
Polar Surface Area: 66.48Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.64CX Basic pKa: 8.98CX LogP: -0.32CX LogD: -1.56
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.58Np Likeness Score: 0.89

References

1. Nathanson JA, Kaugars G..  (1989)  A probe for octopamine receptors: synthesis of 2-[(4-azido-2,6-diethylphenyl)imino]imidazolidine and its tritiated derivative, a potent reversible-irreversible activator of octopamine-sensitive adenylate cyclase.,  32  (8): [PMID:2502628] [10.1021/jm00128a022]
2. Leclerc G, Bizec JC, Bieth N, Schwartz J..  (1980)  Synthesis and structure-activity relationships among alpha-adrenergic receptor agonists of the phenylethanolamine type.,  23  (7): [PMID:6105214] [10.1021/jm00181a008]
3. Petrascheck M, Ye X, Buck LB..  (2007)  An antidepressant that extends lifespan in adult Caenorhabditis elegans.,  450  (7169): [PMID:18033297] [10.1038/nature05991]
4. Bard B, Carrupt PA, Martel S..  (2009)  Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.,  52  (10): [PMID:19397318] [10.1021/jm9003945]
5. PubChem BioAssay data set, 
6. PubChem BioAssay data set, 
7. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
8. HIRASHIMA A, PAN C, KATAFUCHI Y, TANIGUCHI E, ETO M.  (1996)  Synthesis and Octopaminergic-Agonist Activity of 2-(Arylimino)oxazolidines and 2-(Substituted Benzylamino)-2-oxazolines,  21  (4): [10.1584/jpestics.21.419]
9. PubChem BioAssay data set, 
10. Dunn WJ, Wold S..  (1978)  Structure-activity study of beta-adrenergic agents using the SIMCA method of pattern recognition.,  21  (9): [PMID:31486] [10.1021/jm00207a015]
11. PubChem BioAssay data set, 
12. WHO Anatomical Therapeutic Chemical Classification, 
13. Glennon RA..  (2017)  The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.,  60  (7): [PMID:28244748] [10.1021/acs.jmedchem.7b00085]
14. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]
15. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius.  (2021)  HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators,  [10.6019/CHEMBL4808148]
16. Jensen O, Brockmöller J, Dücker C..  (2021)  Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation.,  64  (5.0): [PMID:33606526] [10.1021/acs.jmedchem.0c02047]